MarketFate Therapeutics And Canaan On The List Of Winners And Losers Of Tuesday's US SessionVia News Editorial Team•Jan 30, 2024
MarketCuris And Cyclacel Pharmaceuticals On The List Of Winners And Losers Of Tuesday's US SessionVia News Editorial Team•Nov 21, 2023